Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H29FO6 |
| Molecular Weight | 420.4712 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C
InChI
InChIKey=ZOCUOMKMBMEYQV-GSLJADNHSA-N
InChI=1S/C23H29FO6/c1-13(25)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(26)6-8-20(14,2)23(17,24)18(27)11-21(16,22)3/h6,8,10,16-18,27,29H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1
Isoflupredone is a veterinary drug used in cows, pigs and horses for the treatment of wide range of conditions: ketosis, musculoskeletal disorders, hypersensitivity, infections, inflammatory diseases, etc. The drug belongs to the class of corticosteroids and exerts its therapeutic effect by binding to glucocorticoid and mineralocorticoid receptors of animals.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Animal Glucocorticoid receptor |
|||
Target ID: Animal Mineralocorticoid receptor |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | PREDEF Approved UseBovine Ketosis, Musculoskeletal Conditions, Allergic Reactions, Overwhelming Infections with Severe Toxicity, Shock, etc. Launch Date1959 |
|||
| Palliative | PREDEF Approved UseBovine Ketosis, Musculoskeletal Conditions, Allergic Reactions, Overwhelming Infections with Severe Toxicity, Shock, etc. Launch Date1959 |
|||
| Primary | PREDEF Approved UseBovine Ketosis, Musculoskeletal Conditions, Allergic Reactions, Overwhelming Infections with Severe Toxicity, Shock, etc. Launch Date1959 |
|||
| Curative | PREDEF Approved UseBovine Ketosis, Musculoskeletal Conditions, Allergic Reactions, Overwhelming Infections with Severe Toxicity, Shock, etc. Launch Date1959 |
|||
| Palliative | PREDEF Approved UseBovine Ketosis, Musculoskeletal Conditions, Allergic Reactions, Overwhelming Infections with Severe Toxicity, Shock, etc. Launch Date1959 |
|||
| Palliative | PREDEF Approved UseBovine Ketosis, Musculoskeletal Conditions, Allergic Reactions, Overwhelming Infections with Severe Toxicity, Shock, etc. Launch Date1959 |
Sample Use Guides
The usual intramuscular dose for cattle is 10 to 20 mg, according to the size of the animal and severity of the condition. This dose may be repeated in 12 to 24 hours if indicated. The usual intramuscular dose for horses is 5 to 20 mg repeated as necessary. The usual intramuscular dose for swine is 5 mg for a 300 pound animal.
Route of Administration:
Intramuscular
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C521
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C77005
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
206-423-9
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
DB14640
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
37977
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
55P9TUL75S
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
1364586
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | RxNorm | ||
|
4962
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL1608183
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
338-98-7
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
1348907
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
12600
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
C065592
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
55P9TUL75S
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
100000142026
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
DTXSID3045306
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
m6490
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB107857
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY | |||
|
224246
Created by
admin on Mon Mar 31 17:48:14 GMT 2025 , Edited by admin on Mon Mar 31 17:48:14 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD